Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder.
about
Pharmacotherapy for anxiety disorders in children and adolescentsBehavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescentsPharmacotherapy of aggression in children and adolescents: efficacy and effect sizeChildren with obsessive-compulsive disorder: are they just "little adults"?Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersControlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training for child obsessive-compulsive disorderPharmacotherapy to control behavioral symptoms in children with autismGlutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.Clinical treatment of obsessive compulsive disorderEmerging drugs in Tourette syndrome.Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.Pharmacotherapies in the management of obsessive-compulsive disorder.A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION.Obsessive-compulsive disorder in children and adolescents.Internalizing disorders in early childhood: a review of depressive and anxiety disordersPsychotherapy and medication management strategies for obsessive-compulsive disorder.Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trialAssessment and management of treatment-refractory obsessive-compulsive disorder in children.Monoamine transporters: vulnerable and vital doorkeepers.Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder.A review of the treatment for refractory obsessive-compulsive disorder: from medicine to deep brain stimulation.The epidemiology of psychotropic drug use in children and adolescents.Escitalopram in obsessive-compulsive disorder: a case series.A review of antipsychotics in the treatment of obsessive compulsive disorder.Co-occurring psychiatric disorders in children and adolescents with Tourette syndrome.Benefits of cognitive-behavioural therapy for children and youth with obsessive-compulsive disorder: re-examination of the evidence.Pediatric obsessive-compulsive disorder: a guide to assessment and treatment.Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disordersEscitalopram in Preschool-Age Children Diagnosed with Obsessive Compulsive Disorder: A Case Report .Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review.Diffusion of efficacious interventions for children and adolescents with mental health problems.Escitalopram in the treatment of obsessive-compulsive disorder.Evidence-based psychosocial treatments for child and adolescent obsessive-compulsive disorder.New-generation antidepressants, suicide and depressed adolescents: how should clinicians respond to changing evidence?A neuropsychiatric review of pediatric obsessive-compulsive disorder: etiology and efficacious treatments.Obsessive-compulsive disorder: Evidence-based treatments and future directions for researchClinical characteristics of high-functioning youth with autism spectrum disorder and anxiety.Intensive Family-Based Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder: Applications for Treatment of Medication Partial- or Nonresponders.The Leyton Obsessional Inventory-Child Version Survey Form does not demonstrate adequate psychometric properties in American youth with pediatric obsessive-compulsive disorder.
P2860
Q24239941-EA1ED6D7-CFCA-47B6-86D7-A6FE8BF3434AQ24244030-9E4CA619-40DD-44D5-8752-CD42769E5A85Q24648097-1D298E16-0DC1-40E0-BC95-24D725A1C71DQ24650906-8E248DD7-F5D0-491F-909D-9FAA299AC276Q27009995-4669250D-E74A-4A73-8F2D-FA6C1E7BE01FQ28251282-0E763BF5-8A29-4DBA-89A2-8A0A0D4A1F19Q28265801-B543AB38-E14D-477D-A2C0-9016F3B8F8E0Q31032734-39E34487-4474-41E9-8E49-C52B9FD8FCC3Q33350235-FEF68E92-D4AB-4BA9-8C41-DDEB3EB3CCCFQ34359796-6180B527-B3CD-42C5-B735-CBAAC1B9BB57Q34423658-E9ED7A99-DE93-4F74-85E8-C6DA45E5782DQ34465555-CA0D86EA-33B4-439F-943E-152D55D37BDDQ34547177-CEBAF70C-E490-42A9-A20F-F7DEC609CFFFQ34671104-72EB4066-F1E8-4257-9167-0A97BA5005E9Q34768566-C0C38798-FDFC-4524-802E-1F1CD30706EEQ34984260-7CBD0B1D-EACE-4F99-BD15-5BE28045B6E6Q35212987-D9EB1F86-C8A5-4B01-94F7-64C0CF407C91Q35568012-A199067B-B4E5-419E-9CCC-9FFBCC48FD20Q35697831-9D243C1D-1531-4546-A366-316A192DED2FQ35877150-55AA1D1C-CD99-43B7-8501-931A60FD6985Q35906894-B63C432F-1B49-4AF8-8895-17AE0C52D748Q35936259-0426C436-7E4A-48EB-AF0D-FC3648C0CC22Q36272506-FF30392C-F5FA-4860-92C6-1CAC2CD0FF8EQ36274266-AE2933E4-8A17-46AA-9198-D86A5E68F7D7Q36276544-E8C38B39-7765-4F29-BB3A-C0D5FE38CD8FQ36592777-64FECBFA-9A4E-44A4-9DE3-6367DC4377A8Q36804011-0F05BE7B-B91A-44FC-BD46-39DC0B3D395CQ36871185-7175FD04-BC7B-4EC3-ACCD-F141532BC161Q36873932-44E17883-2C8E-407E-8F48-F0B4604962F1Q36954367-6AC7AE84-93F5-4870-A9A7-CCE29684FBE1Q37054226-B71EB396-F383-46F3-9F7C-66741028E972Q37107519-519FD8A6-F7CD-46A6-AC16-93FCBD4E789DQ37111879-AE5C015C-60B9-4470-A938-FE11E902A305Q37150116-50B2C0FA-C867-42F3-B033-617EEE045909Q37157631-6E699682-97DB-48AF-B201-F72E96CB648EQ37165461-58E525EF-EFE2-41F8-8A3E-DE63C77D8C70Q37195340-EEC10241-9CEA-4FF5-9B80-7B685F87A7D4Q37256995-01341688-290D-41B7-9744-5D87F6CB207EQ37257042-89C5B8FC-A825-4550-8364-D4D885216534Q37257053-533E0AD8-2F31-4FE7-9B34-804AC0D769ED
P2860
Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Which SSRI? A meta-analysis of ...... obsessive-compulsive disorder.
@ast
Which SSRI? A meta-analysis of ...... obsessive-compulsive disorder.
@en
Which SSRI? A meta-analysis of ...... obsessive-compulsive disorder.
@nl
type
label
Which SSRI? A meta-analysis of ...... obsessive-compulsive disorder.
@ast
Which SSRI? A meta-analysis of ...... obsessive-compulsive disorder.
@en
Which SSRI? A meta-analysis of ...... obsessive-compulsive disorder.
@nl
prefLabel
Which SSRI? A meta-analysis of ...... obsessive-compulsive disorder.
@ast
Which SSRI? A meta-analysis of ...... obsessive-compulsive disorder.
@en
Which SSRI? A meta-analysis of ...... obsessive-compulsive disorder.
@nl
P2093
P1476
Which SSRI? A meta-analysis of ...... obsessive-compulsive disorder.
@en
P2093
Andrés Martin
Benjamin Mullin
Daniel A Geller
Joseph Biederman
S Evelyn Stewart
Thomas Spencer
P304
P356
10.1176/APPI.AJP.160.11.1919
P407
P577
2003-11-01T00:00:00Z